ALPS Advisors’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-73,790
| Closed | -$67K | – | 1081 |
|
|
2022
Q1 | $67K | Sell |
73,790
-8,548
| -10% | -$7.76K | ﹤0.01% | 832 |
|
|
2021
Q4 | $660K | Buy |
+82,338
| New | +$660K | 0.01% | 452 |
|
|
2021
Q2 | – | Sell |
-90,714
| Closed | -$600K | – | 915 |
|
|
2021
Q1 | $600K | Buy |
90,714
+1,152
| +1% | +$7.62K | 0.01% | 477 |
|
|
2020
Q4 | $376K | Buy |
89,562
+25,615
| +40% | +$108K | ﹤0.01% | 570 |
|
|
2020
Q3 | $306K | Sell |
63,947
-4,219
| -6% | -$20.2K | ﹤0.01% | 512 |
|
|
2020
Q2 | $414K | Buy |
+68,166
| New | +$414K | 0.01% | 475 |
|
|
2019
Q4 | – | Sell |
-77,479
| Closed | -$446K | – | 850 |
|
|
2019
Q3 | $446K | Sell |
77,479
-3,871
| -5% | -$22.3K | ﹤0.01% | 507 |
|
|
2019
Q2 | $740K | Buy |
+81,350
| New | +$740K | 0.01% | 411 |
|